IMRX CIK: 1790340

Immuneering Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.9
FY22:
−44.1
FY23:
−49.0
FY24:
−55.0
FY25:
−45.3
Change from FY21 to FY25
millions USD
FY21:
−75.6
FY22:
41.8
FY23:
7.30
FY24:
26.4
FY25:
−88.7
Change from FY21 to FY25
millions USD
FY21:
144
FY22:
0.02
FY23:
28.4
FY24:
5.30
FY25:
227
millions USD
FY21:
37.8
FY22:
−2.25
FY23:
−13.2
FY24:
−23.3
FY25:
92.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.9
FY22:
−44.8
FY23:
−49.3
FY24:
−55.1
FY25:
−45.5

All amounts in millions USD Data source:SEC EDGAR